Sources: Dassault Systèmes is in talks to buy drug trial software maker ArisGlobal from Nordic Capital for about $2B, extending its push into life sciences (Financial Times)
Culture Index
Score Breakdown
Relevance
3/25
Freshness
25/25
Authority
25/20
Brand Signal
6/15
Depth
4/15
5-Axis Cultural Radar
Financial Times : Sources: Dassault Systèmes is in talks to buy drug trial software maker ArisGlobal from Nordic Capital for about $2B, extending its push into life sciences — Potential purchase of ArisGlobal from Swedish buyout group would boost French conglomerate's push into life sciences
